Therapies for Pediatric Patients with Sickle Cell Disease

Therapies for Pediatric Patients with Sickle Cell Disease Therapies for Pediatric Patients with Sickle Cell Disease
CME, CNE
Lanetta Bronté-Hall, MD, MPH, MSPH, and Andrew Campbell, MD
 
Release Date: October 25, 2021
Expiration Date: October 25, 2022

In this activity, two experts discuss the care of pediatric patients with sickle cell disease, including updated information on therapies. This activity will conclude with a review of the Florida-based quality improvement study, designed to improve quality of care for patients, and how to implement and monitor the standard of care. Don't miss the opportunity to participate in this QI program led by Dr. Bronté-Hall. Information on how you can participate will be provided at the end of the program. ​

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Novartis Pharmaceuticals.
Begin, Earn CreditView Only, No Credit